argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
704.31
+12.91 (1.87%)
At close: Mar 30, 2026, 4:00 PM EDT
711.30
+6.99 (0.99%)
Pre-market: Mar 31, 2026, 8:15 AM EDT
argenx SE Employees
argenx SE had 1,599 employees as of December 31, 2024. The number of employees increased by 451 or 39.29% compared to the previous year.
Employees
1,599
Change (1Y)
451
Growth (1Y)
39.29%
Revenue / Employee
$2,649,449
Profits / Employee
$808,027
Market Cap
43.57B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 1,599 | 451 | 39.29% |
| Dec 31, 2023 | 1,148 | 305 | 36.18% |
| Dec 31, 2022 | 843 | 193 | 29.69% |
| Dec 31, 2021 | 650 | 314 | 93.45% |
| Dec 31, 2020 | 336 | 148 | 78.72% |
| Dec 31, 2019 | 188 | 83 | 79.05% |
| Dec 31, 2018 | 105 | 32 | 43.84% |
| Dec 31, 2017 | 73 | 15 | 25.86% |
| Dec 31, 2016 | 58 | 17 | 41.46% |
| Dec 31, 2015 | 41 | 9 | 28.13% |
| Dec 31, 2014 | 32 | 10 | 45.45% |
| Dec 31, 2013 | 22 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Regeneron Pharmaceuticals | 15,410 |
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 7,807 |
| Vertex Pharmaceuticals | 6,400 |
| Moderna | 4,700 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| Insmed | 1,664 |
ARGX News
- 5 days ago - $100 Invested In argenx 5 Years Ago Would Be Worth This Much Today - Benzinga
- 6 days ago - eClinical Solutions elluminate® Platform Supports argenx to Enhance Data Oversight and Efficiency - Business Wire
- 13 days ago - Here's How Much $1000 Invested In argenx 5 Years Ago Would Be Worth Today - Benzinga
- 19 days ago - Notable ETF Outflow Detected - IBB, ALNY, INSM, ARGX - Nasdaq
- 20 days ago - Argenx (ARGX) Upgraded by Deutsche Bank with Increased Price Target - GuruFocus
- 21 days ago - Wedbush Reiterates Outperform Rating for argenx (ARGX) with $1000 Price Target | ARGX Stock News - GuruFocus
- 25 days ago - argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline - GlobeNewsWire
- 25 days ago - Oversold Conditions For argenx (ARGX) - Nasdaq